Skip to main content

Table 2 Demographic summary by treatment group (all randomized subjects)

From: Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo-controlled study

 

DDEA 1.16% gel

Placebo

 

(N = 36)

(N = 36)

Age (years) – mean ± SD (range)

29.8 ± 10.5 (19–65)

37.8 ± 15.2 (18–74)

Sex (male) – n (%)

19 (52.8)

14 (38.9)

Time from onset of neck pain (hours) – mean ± SD (range)

246.5 ± 306.5 (23–1491)

248.4 ± 348.3 (22–1691)

Pain-on-movement* (mm) (0 = no pain, 100 = extreme pain) – mean ± SD (range)

77.2 ± 10.5 (57–92)

73.8 ± 9.8 (56–90)

Neck Disability Index score (0 = best outcome, 50 = worst outcome) – mean ± SD (range)

25.3 ± 8.4 (7–37)

23.6 ± 7.3 (9–34)

Pain-at-rest (mm) (0 = no pain, 100 = extreme pain) – mean ± SD (range)

41.1 ± 17.0 (11–79)

40.1 ± 16.9 (5–64)

  1. * Mean score, average of the three VAS scores. DDEA = diclofenac diethylamine; SD = standard deviation.